Seasoned Diagnostic Executives Bolster Leadership in Preparation for Regulatory Process and Commercialization

Charlottesville, VA – May 2, 2015 – HemoSonics, a medical device company developing a point-of-care diagnostic platform to guide the management of critical bleeding, today announced that it has named two seasoned diagnostic executives to lead its development team, David Bryant will serve as HemoSonics’ Vice President of Quality Systems, and Thomas Givens will serve as Vice President of Engineering.

“As we continue to progress towards commercialization of our Quantra Dx™ diagnostic platform, Dave and Thomas bring extensive experience in developing diagnostic instruments for manufacturing and successfully taking them through the regulatory and commercialization process,” said Timothy Fischer, President and Chief Executive Officer of HemoSonics. “We are confident that their leadership will strengthen our abilities to effectively achieve regulatory clearance of our products.”

Bryant is an experienced engineer who has led several teams through the development and registration of novel, high value diagnostic products. Prior to joining HemoSonics, he was Senior Director of Program Management at LipoScience, Inc. and Director of Platform Imaging at Beckton Dickinson Diagnostics, formerly TriPath Imaging. Bryant holds a BS in Industrial Engineering from North Carolina State University.

Givens has extensive experience leading engineering research and development teams of diagnostic products. Prior to joining HemoSonics, he was Senior Director of Engineering R&D At LipoScience, Inc. and Principal Engineer at Beckton Dickinson. Givens hold a BS in Engineering Science from the University of Tennessee and an MS in Mechanical Engineering from Duke University.